Calithera Biosciences, Inc. CALA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

56/100

3/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Calithera Biosciences, Inc. (CALA), dont 25 achats et 25 ventes. Le total des achats d'initiés s'élève à $1.11M et le total des ventes d'initiés à $80.46M.

Les initiés notables ayant une activité récente comprennent Takeda Pharmaceutical Co Ltd, Pakianathan Deepika, Molineaux Susan. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CALA

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-04-17	Takeda Pharmaceutical Co Ltd	Officer	Autre (Vente)	1,000,000	$40.08	$40.08M	-
2023-01-27	Pakianathan Deepika	Director	Vente Informative	1,172	$0.39	$452.16	-
2023-01-23	Molineaux Susan	President & CEO	Retenue Fiscale RSU	526	$0.45	$234.65	27,859
2023-01-23	Wong Stephanie	See Remarks	Retenue Fiscale RSU	317	$0.45	$141.41	6,287
2023-01-23	Sjogren Eric	Sr. VP, Drug Discovery	Retenue Fiscale RSU	279	$0.45	$124.46	8,467
2023-01-23	Molineaux Christopher	Sr. VP, Development	Retenue Fiscale RSU	217	$0.45	$96.80	27,859
2023-01-23	Kuriakose Emil	Chief Medical Officer	Retenue Fiscale RSU	79	$0.45	$35.24	3,539
2022-07-01	Takeda Pharmaceutical Co Ltd	10 Percent Owner	Autre (Vente)	1,000,000	$40.08	$40.08M	-
2022-07-01	Takeda Ventures, Inc.	Director	Autre (Vente)	1,000,000	-	-	-
2022-06-01	Pakianathan Deepika	Director	Attribution de RSU	20,000	-	-	20,000
2022-06-01	Wolff Henry Ward	Director	Attribution de RSU	20,000	-	-	20,000
2022-06-01	Garland J. Scott	Director	Attribution de RSU	20,000	-	-	20,000
2022-06-01	Agarwal Sunil	Director	Attribution de RSU	20,000	-	-	20,000
2022-06-01	Wise Blake	Director	Attribution de RSU	20,000	$0.20	$4K	20,000
2022-06-01	Orford Keith	Director	Attribution de RSU	20,000	$0.20	$4K	20,000
2022-06-01	Jones Suzy	Director	Attribution de RSU	20,000	-	-	20,000
2022-01-25	Molineaux Susan	President & CEO	Attribution de RSU	597,475	$0.44	$262.89K	597,475
2022-01-25	Wong Stephanie	See Remarks	Attribution de RSU	215,000	$0.44	$94.6K	215,000
2022-01-25	Ray Sumita	See Remarks	Attribution de RSU	165,000	$0.44	$72.6K	165,000
2022-01-25	Sjogren Eric	Sr. VP, Drug Discovery	Attribution de RSU	165,000	$0.44	$72.6K	165,000
2022-01-25	Molineaux Christopher	Sr. VP, Development	Attribution de RSU	165,000	$0.44	$72.6K	165,000
2022-01-25	Orford Keith	Director	Attribution de RSU	40,000	$0.44	$17.6K	40,000
2022-01-25	Parlati Francesco	Sr. VP, Research	Attribution de RSU	165,000	$0.44	$72.6K	165,000
2022-01-25	Kuriakose Emil	Chief Medical Officer	Attribution de RSU	215,000	$0.44	$94.6K	215,000
2022-01-21	Wong Stephanie	See Remarks	Retenue Fiscale RSU	5,586	$0.49	$2.75K	132,085
2022-01-21	Sjogren Eric	Sr. VP, Drug Discovery	Retenue Fiscale RSU	4,794	$0.49	$2.36K	172,434
2022-01-21	Parlati Francesco	Sr. VP, Research	Retenue Fiscale RSU	4,794	$0.49	$2.36K	140,998
2022-01-21	Kuriakose Emil	Chief Medical Officer	Retenue Fiscale RSU	666	$0.49	$327.34	67,369
2022-01-04	Wong Stephanie	See Remarks	Retenue Fiscale RSU	18,077	$0.66	$11.94K	137,671
2022-01-04	Sjogren Eric	Sr. VP, Drug Discovery	Retenue Fiscale RSU	18,077	$0.66	$11.94K	177,228
2022-01-04	Parlati Francesco	Sr. VP, Research	Retenue Fiscale RSU	18,077	$0.66	$11.94K	145,792
2022-01-04	Kuriakose Emil	Chief Medical Officer	Retenue Fiscale RSU	3,855	$0.66	$2.55K	68,035
2021-11-11	Orford Keith	Director	Vente Informative	48,190	$0.88	$42.41K	66,094
2021-11-10	Molineaux Susan	President & CEO	Achat Informatif	100,000	$0.85	$84.67K	557,188
2021-11-10	Drachman Jonathan G	Director	Achat Informatif	200,000	$0.86	$171.9K	200,000
2021-11-10	Molineaux Christopher	Sr. VP, Development	Achat Informatif	100,000	$0.85	$84.67K	557,188
2021-11-10	Orford Keith	Director	Vente Informative	30,000	$0.86	$25.7K	114,284
2021-11-09	Orford Keith	Director	Vente Informative	51,810	$0.84	$43.52K	144,284
2021-11-08	Wong Stephanie	See Remarks	Retenue Fiscale RSU	15,566	$0.87	$13.54K	155,748
2021-11-08	Sjogren Eric	Sr. VP, Drug Discovery	Retenue Fiscale RSU	15,566	$0.87	$13.54K	195,305
2021-11-08	Parlati Francesco	Sr. VP, Research	Retenue Fiscale RSU	15,566	$0.87	$13.54K	163,869
2021-11-08	Kuriakose Emil	Chief Medical Officer	Retenue Fiscale RSU	3,077	$0.87	$2.68K	69,390
2021-11-05	Wong Stephanie	See Remarks	Attribution de RSU	30,000	-	-	171,314
2021-11-05	Ray Sumita	See Remarks	Attribution de RSU	12,000	-	-	105,000
2021-11-05	Sjogren Eric	Sr. VP, Drug Discovery	Attribution de RSU	30,000	-	-	210,871
2021-11-05	Molineaux Christopher	Sr. VP, Development	Attribution de RSU	12,000	-	-	102,500
2021-11-05	Orford Keith	Director	Attribution de RSU	30,000	-	-	196,094
2021-11-05	Parlati Francesco	Sr. VP, Research	Attribution de RSU	30,000	-	-	179,435
2021-11-05	Kuriakose Emil	Chief Medical Officer	Cession	33,375	$2.98	$99.46K	-
2021-11-05	Kuriakose Emil	Chief Medical Officer	Attribution de RSU	12,000	-	-	72,467

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration